L3VLUP
ProSign in

TEVA in the 13F filings

Teva Pharmaceutical Inds LTD · CUSIP 881624209

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2023
the date the book describes
Filed
15 Nov 2023
latest of these filings; the earliest 18 Oct 2023
Managers listing it
13
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q2 2023 and Q3 2023; 7 listed it in both
Shares listed
37,676,657
combined, among listed positions
Reported value
$384m
combined, at the quarter end

Managers listing TEVA in Q3 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

13 of 13 holders

ActionFiling
Millennium Management LLC9,857,802$101m0.05%New-4,172,26714 Nov 2023 (the filing on sec.gov)
D. E. Shaw & Co.6,038,675$62m0.06%Addedn.a.14 Nov 2023 (the filing on sec.gov)
Holocene Advisors LP5,122,773$52m0.23%Newnew14 Nov 2023 (the filing on sec.gov)
Renaissance Technologies LLC4,017,900$41m0.07%Trimmed-2,522,16014 Nov 2023 (the filing on sec.gov)
Arrowstreet Capital LP3,945,950$40munder 0.1%Newnew14 Nov 2023 (the filing on sec.gov)
Marshall Wace LLP2,380,974$24munder 0.1%Addedn.a.14 Nov 2023 (the filing on sec.gov)
Point72 Asset Management LP1,631,197$17munder 0.1%Addedn.a.14 Nov 2023 (the filing on sec.gov)
Rokos Capital Management LLP1,355,013$14m0.10%Held014 Nov 2023 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC1,100,757$11m0.09%Added+267,12514 Nov 2023 (the filing on sec.gov)
Two Sigma Advisers LP1,043,200$11munder 0.1%Trimmedn.a.14 Nov 2023 (the filing on sec.gov)
Tudor Investment Corp894,501$9.1m0.09%Added+208,77615 Nov 2023 (the filing on sec.gov)
ARK Investment Management LLC254,810$2.6munder 0.1%Added+16,88718 Oct 2023 (the filing on sec.gov)
Maverick Capital Ltd33,105$338kunder 0.1%Trimmed-17,48314 Nov 2023 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2023 to Q3 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (3)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
22 in Q3 2024 to 14 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
TEVA by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201314$5.5bnn.a.n.a.
Q3 201316$5.9bnn.a.n.a.
Q4 201317$5.4bnn.a.n.a.
Q1 201424$7.7bnn.a.n.a.
Q2 201424$7.3bnn.a.n.a.
Q3 201425$7.4bnn.a.n.a.
Q4 201425$8.1bnn.a.n.a.
Q1 201525$8.7bnn.a.n.a.
Q2 201526$8.2bnn.a.n.a.
Q3 201523$8.4bnn.a.n.a.
Q4 201525$12.8bnn.a.n.a.
Q1 201627$10.3bnn.a.n.a.
Q2 201622$8.8bnn.a.n.a.
Q3 201625$7.9bnn.a.n.a.
Q4 201619$6.6bnn.a.n.a.
Q1 201722$5.9bnn.a.n.a.
Q2 201714$6.2bnn.a.n.a.
Q3 201715$3.0bnn.a.n.a.
Q4 201714$4.1bnn.a.n.a.
Q1 201813$4.8bnn.a.n.a.
Q2 201818$7.0bnn.a.n.a.
Q3 201818$6.3bnn.a.n.a.
Q4 201819$4.9bnn.a.n.a.
Q1 201914$4.7bnn.a.n.a.
Q2 201914$2.8bnn.a.n.a.
Q3 201911$2.0bnn.a.n.a.
Q4 20199$2.9bnn.a.n.a.
Q1 202014$2.0bnn.a.n.a.
Q2 202012$2.8bnn.a.n.a.
Q3 20207$2.1bnn.a.n.a.
Q4 20205$2.2bnn.a.n.a.
Q1 20218$2.6bnn.a.n.a.
Q2 20217$2.1bnn.a.n.a.
Q3 20216$1.7bnn.a.n.a.
Q4 20214$1.1bnn.a.n.a.
Q1 20229$1.4bnn.a.n.a.
Q2 202211$913mn.a.n.a.
Q3 202211$1.4bnn.a.n.a.
Q4 202211$1.7bnn.a.n.a.
Q1 20238$1.3bnn.a.n.a.
Q2 202310$184mn.a.n.a.
Q3 202313$384mn.a.n.a.
Q4 202310$373m83
Q1 202416$666m86
Q2 202422$1.8bn137
Q3 202422$2.3bn912
Q4 202418$3.0bn811
Q1 202512$2.0bn76
Q2 202511$1.8bn65
Q3 202514$964m94
Q4 202516$2.1bn1822
Q1 202614$2.0bn2019
Q2 202614$2.4bn1816

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

TEVA and LLY →TEVA and JNJ →TEVA and VRTX →Choose a stock to compare with TEVA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own TEVA, latest filings →Back to the 13F Explorer →